Menu
GeneBe

rs111695726

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000426.4(LAMA2):c.1403C>G(p.Ala468Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00124 in 1,613,914 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A468A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0066 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00069 ( 14 hom. )

Consequence

LAMA2
NM_000426.4 missense

Scores

12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.15
Variant links:
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016712457).
BP6
Variant 6-129177802-C-G is Benign according to our data. Variant chr6-129177802-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 256052.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-129177802-C-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00658 (1002/152262) while in subpopulation AFR AF= 0.0232 (963/41552). AF 95% confidence interval is 0.022. There are 8 homozygotes in gnomad4. There are 460 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 8 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LAMA2NM_000426.4 linkuse as main transcriptc.1403C>G p.Ala468Gly missense_variant 10/65 ENST00000421865.3
LAMA2NM_001079823.2 linkuse as main transcriptc.1403C>G p.Ala468Gly missense_variant 10/64

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LAMA2ENST00000421865.3 linkuse as main transcriptc.1403C>G p.Ala468Gly missense_variant 10/655 NM_000426.4

Frequencies

GnomAD3 genomes
AF:
0.00657
AC:
999
AN:
152144
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0232
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00151
AC:
379
AN:
251290
Hom.:
5
AF XY:
0.00105
AC XY:
143
AN XY:
135820
show subpopulations
Gnomad AFR exome
AF:
0.0206
Gnomad AMR exome
AF:
0.00110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.000686
AC:
1003
AN:
1461652
Hom.:
14
Cov.:
31
AF XY:
0.000587
AC XY:
427
AN XY:
727134
show subpopulations
Gnomad4 AFR exome
AF:
0.0249
Gnomad4 AMR exome
AF:
0.00114
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000580
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000180
Gnomad4 OTH exome
AF:
0.00154
GnomAD4 genome
AF:
0.00658
AC:
1002
AN:
152262
Hom.:
8
Cov.:
32
AF XY:
0.00618
AC XY:
460
AN XY:
74444
show subpopulations
Gnomad4 AFR
AF:
0.0232
Gnomad4 AMR
AF:
0.00176
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.00179
Hom.:
0
Bravo
AF:
0.00712
ESP6500AA
AF:
0.0225
AC:
99
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00180
AC:
218
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 14, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 10, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
LAMA2-related muscular dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Congenital muscular dystrophy due to partial LAMA2 deficiency Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Merosin deficient congenital muscular dystrophy;C4748327:Muscular dystrophy, limb-girdle, autosomal recessive 23 Benign:1
Benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 14, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.63
Cadd
Benign
20
Dann
Benign
0.96
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.048
N
LIST_S2
Benign
0.72
T;T;T
MetaRNN
Benign
0.017
T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.27
T
Polyphen
0.042
.;.;B
Vest4
0.22
MVP
0.51
MPC
0.10
ClinPred
0.0052
T
GERP RS
3.3
Varity_R
0.15
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs111695726; hg19: chr6-129498947; API